Liu, W., Zhuang, C., Huang, T., Yang, S., Zhang, M., Lin, B., & Jiang, Y. (2020). Loss of CDKN2A at chromosome 9 has a poor clinical prognosis and promotes lung cancer progression. Wiley.
Chicago Style aipamenaLiu, Wei, Congwen Zhuang, Tengfei Huang, Shengsheng Yang, Meiqing Zhang, Baoquan Lin, and Yi Jiang. Loss of CDKN2A at Chromosome 9 Has a Poor Clinical Prognosis and Promotes Lung Cancer Progression. Wiley, 2020.
MLA aipamenaLiu, Wei, et al. Loss of CDKN2A at Chromosome 9 Has a Poor Clinical Prognosis and Promotes Lung Cancer Progression. Wiley, 2020.
Kontuz: berrikusi erreferentzia hauek erabili aurretik.